collection
MENU ▼
Read by QxMD icon Read
search

DIABETES MELLITUS 2015

shared collection
26 papers 25 to 100 followers
By EFRAIN PAEZ Internal Medicine since 1988. Interested in all aspects of Medicine.
https://www.readbyqxmd.com/read/26696689/13-diabetes-care-in-the-hospital
#1
REVIEW
(no author information available yet)
No abstract text is available yet for this article.
January 2016: Diabetes Care
https://www.readbyqxmd.com/read/26586393/extended-dual-antiplatelet-for-diabetic-elderly-patients-after-drug-eluting-stent-implantation-an-evidence-based-clinical-review
#2
REVIEW
Benedicta M Suwita, Purwita W Laksmi, Ika P Wijaya
Antiplatelet is an important drug for patients with coronary heart disease undergoing drug-eluting stent implantation. Current guidelines recommend dual antiplatelet with aspirin and a P2Y12 inhibitor for at least 12 months. Continuation of DAPT beyond 12 months may be considered for preventing very late stent thrombosis. Several patient-related factors that contribute to stent thrombosis have been recognized, including diabetes and advanced age, but the optimal DAPT duration for these patients is still controversial...
July 2015: Acta Medica Indonesiana
https://www.readbyqxmd.com/read/26450220/sodium-glucose-cotransporter-2-inhibitors-in-the-treatment-of-type-2-diabetes-mellitus
#3
Eva Vivian
PURPOSE: The purpose of this review article is to provide guidance to clinicians and diabetes educators regarding the use of sodium-glucose cotransporter 2 (SGLT2) inhibitors as a therapeutic option for the treatment of patients with type 2 diabetes mellitus (T2DM). METHODS: The PubMed database was searched through February 2015 to identify clinical trials and meta-analyses evaluating the use of the SGLT2 inhibitors canagliflozin, dapagliflozin, and empagliflozin administered as monotherapy or in combination with other oral antidiabetes drugs or with insulin...
December 2015: Diabetes Educator
https://www.readbyqxmd.com/read/26369574/what-is-a-normal-blood-glucose
#4
REVIEW
Maria Güemes, Sofia A Rahman, Khalid Hussain
Glucose is the key metabolic substrate for tissue energy production. In the perinatal period the mother supplies glucose to the fetus and for most of the gestational period the normal lower limit of fetal glucose concentration is around 3 mmol/L. Just after birth, for the first few hours of life in a normal term neonate appropriate for gestational age, blood glucose levels can range between 1.4 mmol/L and 6.2 mmol/L but by about 72 h of age fasting blood glucose levels reach normal infant, child and adult values (3...
June 2016: Archives of Disease in Childhood
https://www.readbyqxmd.com/read/26414007/evidence-based-guideline-of-the-german-nutrition-society-fat-intake-and-prevention-of-selected-nutrition-related-diseases
#5
Günther Wolfram, Angela Bechthold, Heiner Boeing, Sabine Ellinger, Hans Hauner, Anja Kroke, Eva Leschik-Bonnet, Jakob Linseisen, Stefan Lorkowski, Matthias Schulze, Peter Stehle, Jessica Dinter
As nutrition-related chronic diseases have become more and more frequent, the importance of dietary prevention has also increased. Dietary fat plays a major role in human nutrition, and modification of fat and/or fatty acid intake could have a preventive potential. The aim of the guideline of the German Nutrition Society (DGE) was to systematically evaluate the evidence for the prevention of the widespread diseases obesity, type 2 diabetes mellitus, dyslipoproteinaemia, hypertension, metabolic syndrome, coronary heart disease (CHD), stroke, and cancer through the intake of fat or fatty acids...
2015: Annals of Nutrition & Metabolism
https://www.readbyqxmd.com/read/26450217/glp-1-receptor-agonists-practical-considerations-for-clinical-practice
#6
Curtis Triplitt, Carolina Solis-Herrera
PURPOSE: Type 2 diabetes (T2D) imparts an increased risk of adverse health outcomes in patients unable to achieve glycemic control. Patient education and individualization of treatment are important for effective management of T2D. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a class of injectable glucose-lowering agents that lower A1C with added benefits of weight loss and improved cardiovascular risk markers. This review discusses the role of GLP-1RAs currently approved in the United States (exenatide, liraglutide, albiglutide, dulaglutide) for T2D management and characterizes the efficacy and safety profiles of individual GLP-1RAs...
December 2015: Diabetes Educator
https://www.readbyqxmd.com/read/26322160/magnesium-and-type-2-diabetes
#7
REVIEW
Mario Barbagallo, Ligia J Dominguez
Type 2 diabetes is frequently associated with both extracellular and intracellular magnesium (Mg) deficits. A chronic latent Mg deficit or an overt clinical hypomagnesemia is common in patients with type 2 diabetes, especially in those with poorly controlled glycemic profiles. Insulin and glucose are important regulators of Mg metabolism. Intracellular Mg plays a key role in regulating insulin action, insulin-mediated-glucose-uptake and vascular tone. Reduced intracellular Mg concentrations result in a defective tyrosine-kinase activity, postreceptorial impairment in insulin action and worsening of insulin resistance in diabetic patients...
August 25, 2015: World Journal of Diabetes
https://www.readbyqxmd.com/read/26421423/withdrawn-metformin-monotherapy-for-type-2-diabetes-mellitus
#8
REVIEW
Antonio Saenz, Inmaculada Fernandez-Esteban, Angel Mataix, Monica Ausejo Segura, Marta Roqué i Figuls, David Moher
No abstract text is available yet for this article.
2015: Cochrane Database of Systematic Reviews
https://www.readbyqxmd.com/read/26397932/long-term-cost-effectiveness-of-initiating-treatment-for-painful-diabetic-neuropathy-with-pregabalin-duloxetine-gabapentin-or-desipramine
#9
Brandon K Bellows, Richard E Nelson, Gary M Oderda, Joanne LaFleur
Painful diabetic neuropathy (PDN) affects nearly half of patients with diabetes. The objective of this study was to compare the cost-effectiveness of starting patients with PDN on pregabalin (PRE), duloxetine (DUL), gabapentin (GABA), or desipramine (DES) over a 10-year time horizon from the perspective of third-party payers in the United States. A Markov model was used to compare the costs (2013 $US) and effectiveness (quality-adjusted life-years [QALYs]) of first-line PDN treatments in 10,000 patients using microsimulation...
January 2016: Pain
https://www.readbyqxmd.com/read/26421334/advances-in-the-science-treatment-and-prevention-of-the-disease-of-obesity-reflections-from-a-diabetes-care-editors-expert-forum
#10
REVIEW
William T Cefalu, George A Bray, Philip D Home, W Timothy Garvey, Samuel Klein, F Xavier Pi-Sunyer, Frank B Hu, Itamar Raz, Luc Van Gaal, Bruce M Wolfe, Donna H Ryan
As obesity rates increase, so too do the risks of type 2 diabetes, cardiovascular disease, and numerous other detrimental conditions. The prevalence of obesity in U.S. adults more than doubled between 1980 and 2010, from 15.0 to 36.1%. Although this trend may be leveling off, obesity and its individual, societal, and economic costs remain of grave concern. In June 2014, a Diabetes Care Editors' Expert Forum convened to review the state of obesity research and discuss the latest prevention initiatives and behavioral, medical, and surgical therapies...
August 2015: Diabetes Care
https://www.readbyqxmd.com/read/26434085/metabolic-correction-as-a-tool-to-improve-diabetes-type-2-management
#11
Jorge R Miranda-Massari, Michael J Gonzalez, Alvarez-Soto Fernando, Carlos Cidre, Iván M Paz, Jorge Charvel, Viridiana Martínez, Jorge Duconge, Aileen Aponte, Carlos M Ricart
Diabetes Mellitus type 2 (DM2) is a metabolic disease that develops by a decrease in sensitivity of insulin receptors as an effect of the disruption certain metabolic functions in the processing of glucose. DM2 patients have, uncontrolled glucose levels, and commonly have problems with obesity and cardiovascular disease. Patients are treated with standard diet, insulin, diabetic oral agents and antihypertensive drugs, but this approach does not completely stops tissue deterioration since it does not address the metabolic root of the disease...
April 2015: Boletín de la Asociación Médica de Puerto Rico
https://www.readbyqxmd.com/read/26175248/guidance-concerning-the-use-of-glycated-haemoglobin-hba1c-for-the-diagnosis-of-diabetes-mellitus
#12
Michael C d'Emden, Jonathan E Shaw, Graham R Jones, N Wah Cheung
Glycated haemoglobin (HbA1c) assessment for the diagnosis of diabetes mellitus overcomes many practical problems associated with traditional blood glucose measurements. However, the test is not without limitations of which the medical practitioner needs to be aware. The possibility of an individual having a medical condition that interferes with the test should always be considered, even though these conditions are rare in most Australian communities. Appropriately used, HbA1c assessment should provide a cost-effective, efficient and simple tool for the early diagnosis of type 2 diabetes...
July 20, 2015: Medical Journal of Australia
https://www.readbyqxmd.com/read/26301188/glycemic-variability-how-do-we-measure-it-and-why-is-it-important
#13
REVIEW
Sunghwan Suh, Jae Hyeon Kim
Chronic hyperglycemia is the primary risk factor for the development of complications in diabetes mellitus (DM); however, it is believed that frequent or large glucose fluctuations may independently contribute to diabetes-related complications. Postprandial spikes in blood glucose, as well as hypoglycemic events, are blamed for increased cardiovascular events in DM. Glycemic variability (GV) includes both of these events; hence, minimizing GV can prevent future cardiovascular events. Correcting GV emerges as a target to be pursued in clinical practice to safely reduce the mean blood glucose and to determine its direct effects on vascular complications in diabetes...
August 2015: Diabetes & Metabolism Journal
https://www.readbyqxmd.com/read/26240703/gestational-diabetes-a-clinical-update
#14
REVIEW
Ulla Kampmann, Lene Ring Madsen, Gitte Oeskov Skajaa, Ditte Smed Iversen, Niels Moeller, Per Ovesen
Gestational diabetes mellitus (GDM) is increasing in prevalence in tandem with the dramatic increase in the prevalence of overweight and obesity in women of childbearing age. Much controversy surrounds the diagnosis and management of gestational diabetes, emphasizing the importance and relevance of clarity and consensus. If newly proposed criteria are adopted universally a significantly growing number of women will be diagnosed as having GDM, implying new therapeutic challenges to avoid foetal and maternal complications related to the hyperglycemia of gestational diabetes...
July 25, 2015: World Journal of Diabetes
https://www.readbyqxmd.com/read/25638784/atypical-mycobacterial-infection-in-insulin-injection-sites
#15
T W Yew, N S Chandran, K B Tan, A C Thai
No abstract text is available yet for this article.
August 2015: QJM: Monthly Journal of the Association of Physicians
https://www.readbyqxmd.com/read/25770159/the-management-of-type-1-and-type-2-diabetes-in-pregnancy
#16
REVIEW
A M Egan, H R Murphy, F P Dunne
Pregestational diabetes is a common medical complication of pregnancy and preconception planning is an essential component of care for affected women of childbearing age. Once pregnant, structured care in a multidisciplinary team setting is necessary to ensure optimal outcomes. Although significant progress has been made, these women and their offspring remain to have a significantly elevated risk of multiple adverse complications. Structured programmes using information technology and enabling access to novel technologies may facilitate our goal of ensuring an outcome closer to that of a pregnancy unaffected by diabetes...
December 2015: QJM: Monthly Journal of the Association of Physicians
https://www.readbyqxmd.com/read/26025688/musculoskeletal-manifestations-of-diabetes-mellitus
#17
REVIEW
M Merashli, T A Chowdhury, A S M Jawad
The prevalence of Type 1 and Type 2 diabetes are increasing significantly worldwide. Whilst vascular complications of diabetes are well recognized, and account for principle mortality and morbidity from the condition, musculoskeletal manifestations of diabetes are common and whilst not life threatening, are an important cause of morbidity, pain and disability. Joints affected by diabetes include peripheral joints and the axial skeleton. Charcot neuroarthropathy is an important cause of deformity and amputation associated with peripheral neuropathy...
November 2015: QJM: Monthly Journal of the Association of Physicians
https://www.readbyqxmd.com/read/26302146/beyond-body-mass-index-advantages-of-abdominal-measurements-for-recognizing-cardiometabolic-disorders
#18
Henry S Kahn, Kai McKeever Bullard
BACKGROUND: The clinical recognition of cardiometabolic disorders might be enhanced by anthropometry based on the sagittal abdominal diameter (SAD; also called "abdominal height") or waist circumference rather than on weight. Direct comparisons of body mass index (BMI, weight/height(2)) with SAD/height ratio (SADHtR) or waist circumference/height ratio (WHtR) have not previously been tested in nationally representative populations. METHODS: Nonpregnant adults without diagnosed diabetes (ages 20-64 years; n = 3071) provided conventional anthropometry and supine SAD (by sliding-beam caliper) in the 2011-2012 US National Health and Nutrition Examination Survey...
January 2016: American Journal of Medicine
https://www.readbyqxmd.com/read/26246459/update-on-prevention-of-cardiovascular-disease-in-adults-with-type-2-diabetes-mellitus-in-light-of-recent-evidence-a-scientific-statement-from-the-american-heart-association-and-the-american-diabetes-association
#19
REVIEW
Caroline S Fox, Sherita Hill Golden, Cheryl Anderson, George A Bray, Lora E Burke, Ian H de Boer, Prakash Deedwania, Robert H Eckel, Abby G Ershow, Judith Fradkin, Silvio E Inzucchi, Mikhail Kosiborod, Robert G Nelson, Mahesh J Patel, Michael Pignone, Laurie Quinn, Philip R Schauer, Elizabeth Selvin, Dorothea K Vafiadis
Cardiovascular disease risk factor control as primary prevention in patients with type 2 diabetes mellitus has changed substantially in the past few years. The purpose of this scientific statement is to review the current literature and key clinical trials pertaining to blood pressure and blood glucose control, cholesterol management, aspirin therapy, and lifestyle modification. We present a synthesis of the recent literature, new guidelines, and clinical targets, including screening for kidney and subclinical cardiovascular disease for the contemporary management of patients with type 2 diabetes mellitus...
September 2015: Diabetes Care
https://www.readbyqxmd.com/read/26246173/update-on-prevention-of-cardiovascular-disease-in-adults-with-type-2-diabetes-mellitus-in-light-of-recent-evidence-a-scientific-statement-from-the-american-heart-association-and-the-american-diabetes-association
#20
REVIEW
Caroline S Fox, Sherita Hill Golden, Cheryl Anderson, George A Bray, Lora E Burke, Ian H de Boer, Prakash Deedwania, Robert H Eckel, Abby G Ershow, Judith Fradkin, Silvio E Inzucchi, Mikhail Kosiborod, Robert G Nelson, Mahesh J Patel, Michael Pignone, Laurie Quinn, Philip R Schauer, Elizabeth Selvin, Dorothea K Vafiadis
Cardiovascular disease risk factor control as primary prevention in patients with type 2 diabetes mellitus has changed substantially in the past few years. The purpose of this scientific statement is to review the current literature and key clinical trials pertaining to blood pressure and blood glucose control, cholesterol management, aspirin therapy, and lifestyle modification. We present a synthesis of the recent literature, new guidelines, and clinical targets, including screening for kidney and subclinical cardiovascular disease for the contemporary management of patients with type 2 diabetes mellitus...
August 25, 2015: Circulation
label_collection
label_collection
5260
1
2
2015-08-27 13:50:36
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"